
NEWLAND PHARMACEUTICAL CO., LTD — Investor Relations & Filings
Newland Pharmaceutical Co., Ltd. is a specialized enterprise engaged in the research, development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs) and high-quality chemical intermediates. The company focuses on a broad spectrum of therapeutic categories, including cardiovascular, anti-infective, and metabolic health solutions. Operating with a commitment to rigorous quality control, its production facilities are designed to meet international Good Manufacturing Practice (GMP) standards. Newland Pharmaceutical prioritizes technological innovation and chemical synthesis optimization to deliver reliable pharmaceutical components. Its core operations involve the large-scale production of complex molecules, supporting the supply chains of healthcare providers and pharmaceutical formulators worldwide through a focus on technical excellence and regulatory compliance.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 股东会议事规则 | 2025-12-08 | Chinese | |
| 董事和高级管理人员所持本公司股份及其变动管理制度 | 2025-12-08 | Chinese | |
| 重大信息内部报告制度 | 2025-12-08 | Chinese | |
| 提名委员会工作制度 | 2025-12-08 | Chinese | |
| 舆情管理制度 | 2025-12-08 | Chinese | |
| 董事离职管理制度 | 2025-12-08 | Chinese |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 44552558 | 股东会议事规则 | 2025-12-08 | Chinese | ||
| 44552538 | 董事和高级管理人员所持本公司股份及其变动管理制度 | 2025-12-08 | Chinese | ||
| 44552526 | 重大信息内部报告制度 | 2025-12-08 | Chinese | ||
| 44552517 | 提名委员会工作制度 | 2025-12-08 | Chinese | ||
| 44552507 | 舆情管理制度 | 2025-12-08 | Chinese | ||
| 44552495 | 董事离职管理制度 | 2025-12-08 | Chinese | ||
| 44552487 | 董事及高级管理人员薪酬与考核管理制度 | 2025-12-08 | Chinese | ||
| 44552476 | 华泰联合证券有限责任公司关于新天地药业股份有限公司募集资金投资项目结项并将节余募集资金永久补充流动资金及注销募集资金专户的核查意见 | 2025-12-08 | Chinese | ||
| 44552461 | 新天地药业股份有限公司关于召开2025年第三次临时股东会的通知 | 2025-12-08 | Chinese | ||
| 44552451 | 第六届董事会第九次会议决议公告 | 2025-12-08 | Chinese | ||
| 44552450 | 董事会议事规则 | 2025-12-08 | Chinese | ||
| 44552441 | 战略委员会工作制度 | 2025-12-08 | Chinese | ||
| 44552431 | 日常生产经营决策制度 | 2025-12-08 | Chinese | ||
| 44552422 | 关联交易管理制度 | 2025-12-08 | Chinese | ||
| 44552414 | 华泰联合证券有限责任公司关于新天地药业股份有限公司首次公开发行前已发行股份解除限售并上市流通的核查意见 | 2025-11-11 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
NEWLAND PHARMACEUTICAL CO., LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56196/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56196 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56196 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56196 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56196}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NEWLAND PHARMACEUTICAL CO., LTD (id: 56196)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.